Related Experiment Video
Updated: Jan 12, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
MEK5 suppresses osteoblastic differentiation
Shoichi Kaneshiro1, Dai Otsuki2, Kiyoshi Yoshida2
1Department of Orthopaedic Surgery, Japan Community Health Care Organization Osaka Hospital, 4-2-78 Fukushima, Fukushima Ward, Osaka City, Osaka 553-0003, Japan; Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Extracellular signal-regulated kinase 5 (ERK5) is a member of the mitogen-activated protein kinase (MAPK) family and is activated by its upstream kinase, MAPK kinase 5 (MEK5), which is a member of the MEK family. Although the role of MEK5 has been investigated in several fields, little is known about its role in osteoblastic differentiation. In this study, we have demonstrated the role of MEK5 in osteoblastic differentiation in mouse preosteoblastic MC3T3-E1 cells and bone marrow stromal ST2 cells. We found that treatment with BIX02189, an inhibitor of MEK5, increased alkaline phosphatase (ALP) activity and the gene expression of ALP, osteocalcin (OCN) and osterix, as well as it enhanced the calcification of the extracellular matrix. Moreover, osteoblastic cell proliferation decreased at a concentration of greater than 0.5 μM. In addition, knockdown of MEK5 using siRNA induced an increase in ALP activity and in the gene expression of ALP, OCN, and osterix. In contrast, overexpression of wild-type MEK5 decreased ALP activity and attenuated osteoblastic differentiation markers including ALP, OCN and osterix, but promoted cell proliferation. In summary, our results indicated that MEK5 suppressed the osteoblastic differentiation, but promoted osteoblastic cell proliferation. These results implied that MEK5 may play a pivotal role in cell signaling to modulate the differentiation and proliferation of osteoblasts. Thus, inhibition of MEK5 signaling in osteoblasts may be of potential use in the treatment of osteoporosis.
Insights
MAPK kinase 5 (MEK5) inhibits osteoblast differentiation but promotes cell proliferation. Inhibiting MEK5 signaling may offer a therapeutic strategy for osteoporosis treatment.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mitogen-activated protein kinase (MAPK) signaling pathways regulate numerous cellular processes.
- Extracellular signal-regulated kinase 5 (ERK5) is activated by MAPK kinase 5 (MEK5).
- The role of MEK5 in osteoblastic differentiation remains largely unexplored.
Purpose of the Study:
- To investigate the role of MEK5 in osteoblastic differentiation.
- To explore MEK5's function in regulating osteoblast proliferation.
Main Methods:
- Utilized MEK5 inhibitor BIX02189 in mouse preosteoblastic MC3T3-E1 and bone marrow stromal ST2 cells.
- Employed small interfering RNA (siRNA) for MEK5 knockdown.
- Performed gene expression analysis for osteoblastic markers (ALP, OCN, osterix).
- Assessed extracellular matrix calcification and cell proliferation.
Main Results:
- MEK5 inhibition (BIX02189 or siRNA) increased alkaline phosphatase (ALP) activity, osteocalcin (OCN), and osterix gene expression, enhancing matrix calcification.
- MEK5 inhibition decreased osteoblastic cell proliferation at concentrations >0.5 μM.
- MEK5 overexpression attenuated osteoblastic differentiation markers but promoted cell proliferation.
Conclusions:
- MEK5 acts as a suppressor of osteoblastic differentiation.
- MEK5 promotes osteoblastic cell proliferation.
- Targeting MEK5 signaling presents a potential therapeutic avenue for osteoporosis.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Mesenchymal Stem Cells
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification
TGF - β Signaling Pathway

